Functional polymorphisms of the hOGG1 gene confer risk to type 2 epithelial ovarian cancer in chinese

International Journal of Gynecological Cancer

Volumn 21, Issue 8, 2011, Pages 1407-1413

  Chen, Xiaoxiang ^a,b   Liu, Xiufang ^a   Wang, Jingmei ^a   Guo, Wenwen ^a   Sun, Caixia ^a   Cai, Zhenming ^a   Wu, Qiang ^b   Xu, Xia ^b   Wang, Yaping ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b JIANGSU CANCER HOSPITAL   (China)

Author keywords

5 UTR; Epithelial ovarian cancer; hOGG1 gene; Single nucleotide polymorphism

Indexed keywords

8 OXOGUANINE DNA GLYCOSYLASE; DNA GLYCOSYLTRANSFERASE; PROTEIN P53; UNCLASSIFIED DRUG; OXOGUANINE GLYCOSYLASE 1, HUMAN;

5' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; EPITHELIAL OVARIAN CANCER TYPE 1; EPITHELIAL OVARIAN CANCER TYPE 2; EXON; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MISSENSE MUTATION; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; CARCINOMA; CHINA; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; METABOLISM; MIDDLE AGED; OVARY; OVARY TUMOR; PATHOLOGY;

5' UNTRANSLATED REGIONS; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA; CASE-CONTROL STUDIES; CHINA; DNA GLYCOSYLASES; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARIAN NEOPLASMS; OVARY; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 84863247608     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31823122c6     Document Type: Article

References (26)

1. Yang L, Parkin DM, Ferlay J, et al. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev. 2005;14:243-250. (Pubitemid 40165308)
2. Shih IeM, Kurman RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol. 2004;164:1511-1518. (Pubitemid 38529752)
3. Fehrmann RS, Li XY, van der Zee AG, et al. Profiling studies in ovarian cancer: a review. Oncologist. 2007;12:960-966. (Pubitemid 47359138)
4. Karihtala P, Soini Y, Vaskivuo L, et al. DNA adduct 8- hydroxydeoxyguanosine, a novel putative marker of prognostic significance in ovarian carcinoma. Int J Gynecol Cancer. 2009;19:1047-1051.
5. Pylvas M, Puistola U, Kauppila S, et al. Oxidative stress-induced antioxidant enzyme expression is an early phenomenon in ovarian carcinogenesis. Eur J Cancer. 2010;46:1661-1667.
6. Klaver CC, Allikmets R. Genetics of macular dystrophies and implications for age-related macular degeneration. Dev Ophthalmol. 2003;37:155-169.
7. Arcand SL, Provencher D, Mes-Masson AM, et al. OGG1 Cys326 variant, allelic imbalance of chromosome band 3p25.3 and TP53 mutations in ovarian cancer. Int J Oncol. 2005;27:1315-1320.
8. Pieretti M, Khattar NH, Smith SA. Common polymorphisms and somatic mutations in human base excision repair genes in ovarian and endometrial cancers. Mutat Res. 2001;432:53-59. (Pubitemid 32144948)
9. Ishida T, Takashima R, Fukayama M, et al. New DNA polymorphisms of human MMH/OGG1 gene: prevalence of one polymorphism among lung-adenocarcinoma patients in Japanese. Int J Cancer. 1999;80:18-21. (Pubitemid 28559769)
10. Kim JC, Ka IH, Lee YM, et al. MYH, OGG1, MTH1, and APC alterations involved in the colorectal tumorigenesis of Korean patients with multiple adenomas. Virchows Arch. 2007;450:311-319. (Pubitemid 46376563)
11. Sun C, Liu X, Zhang H, et al. Functional polymorphism of hOGG1 gene is associated with type 2 diabetes mellitus in Chinese population. Mol Cell Endocrinol. 2010;325:128-134.
12. Chen X, Wang J, Guo W, et al. Two functional variations in 5′-UTR of hoGG1 gene associated with the risk of breast cancer in Chinese. Breast Cancer Res Treat. 2011;127:795-803.
13. Bocker W. WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics. Verh Dtsch Ges Pathol. 2002;86:116-119.
14. Silverberg SG. Histopathologic grading of ovarian carcinoma: a review and proposal. Int J Gynecol Pathol. 2000;19:7-15. (Pubitemid 30010638)
15. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25:118-145. (Pubitemid 350003059)
16. Nam EJ, Kim YT. Alteration of cell-cycle regulation in epithelial ovarian cancer. Int J Gynecol Cancer. 2008;18:1169-1182.
17. Loft S, Moller P. Oxidative DNA damage and human cancer: need for cohort studies. Antioxid Redox Signal. 2006;8:1021-1031. (Pubitemid 44036519)
18. Hill JW, Evans MK. Dimerization and opposite base-dependent catalytic impairment of polymorphic S326C OGG1 glycosylase. Nucleic Acids Res. 2006;34:1620-1632.
19. Puisieux A, Lim S, Groopman J, et al. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res. 1991;51:6185-6189.
20. Corney DC, Flesken-Nikitin A, Choi J, et al. Role of p53 and Rb in ovarian cancer. Adv Exp Med Biol. 2008;622:99-117.
21. Singer G, Stohr R, Cope L, et al. Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation. Am J Surg Pathol. 2005;29:218-224. (Pubitemid 40170640)
22. Salani R, Kurman RJ, Giuntoli R 2nd, et al. Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance. Int J Gynecol Cancer. 2008;18:487-491. (Pubitemid 351668307)
23. Reisman D, McFadden JW, Lu G. Loss of heterozygosity and p53 expression in Pterygium. Cancer Lett. 2004;206:77-83. (Pubitemid 38281257)
24. Palozza P, Serini S, Di Nicuolo F, et al. Beta-carotene exacerbates DNA oxidative damage and modifies p53-related pathways of cell proliferation and apoptosis in cultured cells exposed to tobacco smoke condensate. Carcinogenesis. 2004;25:1315-1325. (Pubitemid 39162698)
25. Youn CK, Song PI, Kim MH, et al. Human 8-oxoguanine DNA glycosylase suppresses the oxidative stress induced apoptosis through a p53-mediated signaling pathway in human fibroblasts. Mol Cancer Res. 2007;5:1083-1098. (Pubitemid 350070763)
26. Seidl H, Kreimer-Erlacher H, Back B, et al. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis. J Invest Dermatol. 2001;117:365-370. (Pubitemid 34205724)